Showing results (111-120 of 1,297) with videos related to
Sort By:
Pageof 130
Australian and New Zealand Journal of Public Health|October 13, 2007
Trends in the incidence of treated end-stage kidney disease among Indigenous Australians and access to treatmentAnnie Preston-Thomas, Alan Cass, Peter O'RourkeAustralian Family Physician|September 12, 2013
ACEIs for cardiovascular risk reduction--have we taken our eye off the ball?Andrew Sindone, Jonathan Erlich, Vlado Perkovic, et al.Diabetes, Obesity & Metabolism|February 3, 2022
Impact of random variation in albuminuria and estimated glomerular filtration rate on patient enrolment and duration of clinical trials in nephrologySimke W Waijer, Michele Provenzano, Skander Mulder, et al.Journal of the American Society of Nephrology : JASN|February 3, 2017
A Trial of Extending Hemodialysis Hours and Quality of LifeMeg J Jardine, Li Zuo, Nicholas A Gray, et al.Australian and New Zealand Journal of Public Health|January 7, 2004
Cause of death in patients with end-stage renal disease: assessing concordance of death certificates with registry reportsShu Qin Li, Alan Cass, Joan CunninghamThe Medical Journal of Australia|May 18, 2005
Bridging the treatment gap for Indigenous Australians. Demands for efficiency should not be met at the expense of equityJoan Cunningham, Alan Cass, Peter C ArnoldDiabetes, Obesity & Metabolism|February 19, 2021
Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trialMin Jun, Katie Harris, Hiddo J L Heerspink, et al.Diabetes, Obesity & Metabolism|October 12, 2020
Sodium-glucose co-transporter-2 inhibitors with and without metformin: A meta-analysis of cardiovascular, kidney and mortality outcomesBrendon L Neuen, Clare Arnott, Vlado Perkovic, et al.European Heart Journal|October 15, 2008
Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trialsFiona Turnbull, Mark Woodward, Bruce Neal, et al.The Cochrane Database of Systematic Reviews|April 17, 2009
HMG CoA reductase inhibitors (statins) for kidney transplant recipientsSankar D Navaneethan, Vlado Perkovic, David W Johnson, et al.Pageof 130